Загрузка...
A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study
BACKGROUND: The current standard postoperative treatment for stage II-IIIA non-small cell lung cancer (NSCLC) is a regimen of platinum doublet adjuvant chemotherapy. These regimens, which are the same as for solid NSCLC tumors, often cause severe adverse reactions in the treated patients. Therefore,...
Сохранить в:
Опубликовано в: : | BMC Cancer |
---|---|
Главные авторы: | , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
BioMed Central
2021
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7941711/ https://ncbi.nlm.nih.gov/pubmed/33685421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07945-y |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|